ALLENA PHARMACEUTICALS INC's ticker is ALNA and the CUSIP is 018119107. A total of 29 filers reported holding ALLENA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $168,000 | -34.4% | 284,285 | 0.0% | 0.01% | -25.0% |
Q3 2021 | $256,000 | -30.8% | 284,285 | 0.0% | 0.01% | -33.3% |
Q2 2021 | $370,000 | -6.3% | 284,285 | 0.0% | 0.01% | 0.0% |
Q1 2021 | $395,000 | +8.5% | 284,285 | 0.0% | 0.01% | -7.7% |
Q4 2020 | $364,000 | -13.5% | 284,285 | 0.0% | 0.01% | -31.6% |
Q3 2020 | $421,000 | -6.2% | 284,285 | 0.0% | 0.02% | -17.4% |
Q2 2020 | $449,000 | +63.9% | 284,285 | 0.0% | 0.02% | 0.0% |
Q1 2020 | $274,000 | -85.7% | 284,285 | -41.6% | 0.02% | -59.6% |
Q3 2019 | $1,919,000 | -40.2% | 486,978 | -38.3% | 0.06% | -6.6% |
Q2 2019 | $3,211,000 | -68.7% | 788,958 | -46.1% | 0.06% | -73.1% |
Q1 2019 | $10,272,000 | +6.6% | 1,463,208 | -17.2% | 0.23% | -11.3% |
Q4 2018 | $9,636,000 | -49.3% | 1,768,104 | -0.0% | 0.26% | -7.9% |
Q3 2018 | $18,994,000 | -16.2% | 1,768,568 | +1.7% | 0.28% | -21.7% |
Q2 2018 | $22,670,000 | +48.7% | 1,739,805 | +18.8% | 0.36% | +14.5% |
Q1 2018 | $15,241,000 | +15.0% | 1,463,894 | -0.0% | 0.31% | -1.3% |
Q4 2017 | $13,255,000 | – | 1,464,204 | – | 0.31% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP II, LLC | 2,790,964 | $3,572,000 | 2.49% |
AIGH Capital Management LLC | 2,000,000 | $2,560,000 | 1.04% |
Worth Venture Partners, LLC | 510,200 | $653,000 | 0.52% |
FRAZIER MANAGEMENT LLC | 3,330,373 | $4,263,000 | 0.33% |
SABBY MANAGEMENT, LLC | 269,836 | $345,000 | 0.07% |
Anson Funds Management LP | 217,251 | $278,000 | 0.06% |
Golden Green, Inc. | 39,000 | $50,000 | 0.05% |
Point72 Asset Management, L.P. | 4,000,000 | $5,120,000 | 0.02% |
PFM Health Sciences, LP | 284,285 | $364,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 158,800 | $203,000 | 0.00% |